Literature DB >> 12957826

Regulation of stromal proliferation, growth arrest, differentiation and apoptosis in benign prostatic hyperplasia by TGF-beta.

Xuemei Huang1, Chung Lee.   

Abstract

This study deals with the biological role of transforming growth factor-beta (TGF-beta) in the pathogenesis of benign prostatic hyperplasia (BPH), which is a common disorder in aging males. The two known etiological factors for BPH have been the presence of testis and aging. It is well established that androgen plays an important role in the pathogenesis of BPH in aging men. The action of androgen is mediated through actions of a host of soluble growth factors, among which TGF-beta is the most versatile in its ability to regulate proliferation, growth arrest, differentiation, and apoptosis of prostatic stromal cells. It is known that BPH development involves a steady increase in the stromal compartment. A subsequent differentiation process of smooth muscle cells in the prostate is responsible for the development bladder neck obstruction secondary to BPH. However, the manner in which the testis and aging mediate the expansion in prostatic stromal compartment and the subsequent smooth muscle differentiation remains unclear. It has become increasingly apparent that TGF-beta intimately regulates the various events associated with the development of BPH. This chapter will present evidence to support the above claim (Figure 1).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12957826     DOI: 10.2741/1093

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  23 in total

Review 1.  Up for Mischief? IL-17/Th17 in the tumour microenvironment.

Authors:  E Maniati; R Soper; T Hagemann
Journal:  Oncogene       Date:  2010-08-23       Impact factor: 9.867

2.  Mechanisms of prostate atrophy after LHRH antagonist cetrorelix injection: an experimental study in a rat model of benign prostatic hyperplasia.

Authors:  Dong Yang; Teng Hou; Xiong Yang; Yan Ma; Longwang Wang; Bing Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2012-06-09

3.  Elevated neutrophil elastase and acrolein-protein adducts are associated with W256 regression.

Authors:  M Jaganjac; M Poljak-Blazi; R J Schaur; K Zarkovic; S Borovic; A Cipak; M Cindric; K Uchida; G Waeg; N Zarkovic
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

4.  Endocrine-immune-paracrine interactions in prostate cells as targeted by phytomedicines.

Authors:  Nora E Gray; Xunxian Liu; Renee Choi; Marc R Blackman; Julia T Arnold
Journal:  Cancer Prev Res (Phila)       Date:  2009-01-13

5.  Targeting androgen receptor to suppress macrophage-induced EMT and benign prostatic hyperplasia (BPH) development.

Authors:  Tianjing Lu; Wen-Jye Lin; Kouji Izumi; Xiaohai Wang; Defeng Xu; Lei-Ya Fang; Lei Li; Qi Jiang; Jie Jin; Chawnshang Chang
Journal:  Mol Endocrinol       Date:  2012-08-21

Review 6.  Animal models of benign prostatic hyperplasia.

Authors:  Junjie Zhang; Mengda Zhang; Jin Tang; Guangming Yin; Zhi Long; Leye He; Chuanchi Zhou; Lufeng Luo; Lin Qi; Long Wang
Journal:  Prostate Cancer Prostatic Dis       Date:  2020-09-01       Impact factor: 5.554

Review 7.  Promising molecular targets and biomarkers for male BPH and LUTS.

Authors:  Mehrnaz Gharaee-Kermani; Jill A Macoska
Journal:  Curr Urol Rep       Date:  2013-12       Impact factor: 3.092

8.  Targeting stromal androgen receptor suppresses prolactin-driven benign prostatic hyperplasia (BPH).

Authors:  Kuo-Pao Lai; Chiung-Kuei Huang; Lei-Ya Fang; Kouji Izumi; Chi-Wen Lo; Ronald Wood; Jon Kindblom; Shuyuan Yeh; Chawnshang Chang
Journal:  Mol Endocrinol       Date:  2013-07-26

9.  A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia.

Authors:  Paloma Alonso-Magdalena; Clemens Brössner; Angelika Reiner; Guojun Cheng; Nobuhiro Sugiyama; Margaret Warner; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-05       Impact factor: 11.205

10.  Low-power GaAlAs laser irradiation promotes the proliferation and osteogenic differentiation of stem cells via IGF1 and BMP2.

Authors:  Jyun-Yi Wu; Yan-Hsiung Wang; Gwo-Jaw Wang; Mei-Ling Ho; Chau-Zen Wang; Ming-Long Yeh; Chia-Hsin Chen
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.